Moxibustion treatment restoring the intestinal epithelium barrier in rats with Crohn's disease by down-regulating tumor necrosis factor alpha, tumor necrosis factor receptor 1, and tumor necrosis factor receptor 2

Chinese Journal of Integrative Medicine

Volumn 17, Issue 3, 2011, Pages 212-217

  Shi, Yin ^a   Zhou, En Hua ^a,b   Wu, Huan Gan ^a   Zhou, Ci Li ^a   Wang, Qian Yao ^a   Qi, Li ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Crohn's disease; Moxibustion; Tumor necrosis factor alpha; Tumor necrosis factor receptor 1; Tumor necrosis factor receptor 2

Indexed keywords

SALAZOSULFAPYRIDINE; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; INTESTINE EPITHELIUM; INTESTINE MUCOSA; MALE; MORPHOLOGY; MOXIBUSTION; NONHUMAN; PRIORITY JOURNAL; RAT; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; CELL MEMBRANE PERMEABILITY; CROHN DISEASE; DISEASE MODELS, ANIMAL; DOWN-REGULATION; INTESTINAL MUCOSA; MALE; MOXIBUSTION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79952539983     PISSN: 16720415     EISSN: 19930402     Source Type: Journal    
DOI: 10.1007/s11655-011-0669-3     Document Type: Article

References (36)

1. Li Q, Zhang Q, Wang M, Zhao S, Ma J, Luo N, et al. Interferon-gamma and tumor necrosis factor-alpha disrupt epithelial barrier function by altering lipid composition in membrane microdomains of tight junction. Clin Immunol 2008;126:67-80. (Pubitemid 350266450)
2. Ye D, Ma I, Ma TY. Molecular mechanism of tumor necrosis factor-alpha modulation of intestinal epithelial tight junction barrier. Am J Physiol Gastrointest Liver Physiol 2006;290:G496-504.
3. van Dullemen HM, van Deventer SJ, Hommes DW, Bijl HA, Jansen J, Tytgat GN, et al. Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology 1995;109:129-135.
4. Suenaert P, Bulteel V, Lemmens L, Noman M, Geypens B, Van Assche G, et al. Anti-tumor necrosis factor treatment restores the gut barrier in Crohn's disease. Am J Gastroenterol 2002; 97: 2000-2004.
5. Hanauer SB, Sandborn WJ, Rutgeerts P, Fedorak RN, Lukas M, MacIntosh D, et al. Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial. Gastroenterology 2006;130:323-333.
6. Mitoma H, Horiuchi T, Hatta N, Tsukamoto H, Harashima S, Kikuchi Y, et al. Infliximab induces potent anti-inflammatory responses by outside-to-inside signals through transmembrane TNF-alpha. Gastroenterology 2005;128:376-392. (Pubitemid 40431090)
7. Shi Y, Liu HR, Hua WG, Qin XD, Wu HG, Qian JL. Study on the modulating mechanism of colonic TNF-α and IL-10mRNA expression in CD rats with acupuncture and moxibustion. Chin Arch Tradit Chin Med (Chin) 2005;23:272-275.
8. Shi Y, Wu HG. Clinical research of herbs-partition moxibustion treating Crohn's disease. Jiangxi J Tradit Chin Med (Chin) 2003;34(8):16-17.
9. Shi Y, Wu HG, Qin XD, Tan LY, Zhang W, Hua XG, et al. The acupuncture effect on E-selectin and ICAM-1 expression in the colonic mucosa with Crohn's disease rats. J Jiangxi Univ Tradit Chin Med (Chin) 2005;17:37-39.
10. Liu HR, Hua XG, Shi Y, Tan LY, Zhang LS. Effects of acupuncture and moxibustion on substance P and neurokinin-1 receptor in Crohn's disease rats. Acta Univ Tradit Med Sinensis Pharmacol Shanghai (Chin) 2005;19(2): 48-50.
11. Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, Wallace JL. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 1989; 96:795-803. (Pubitemid 19057602)
12. Elson CO. Genes, microbes, and T cells-new therapeutic targets in Crohn's disease. N Engl J Med 2002; 346:614-616. (Pubitemid 34438824)
13. Shanahan F. Crohn's disease. Lancet 2002;359:62-69. (Pubitemid 34119201)
14. Shen L, Su L, Turner JR. Mechanisms and functional implications of intestinal barrier defects. Dig Dis 2009; 27:443-449.
15. Mankertz J, Schulzke JD. Altered permeability in inflammatory bowel disease: pathophysiology and clinical implications. Curr Opin Gastroenterol 2007;23:379-383. (Pubitemid 46878948)
16. Troeger H, Richter JF, Beutin L, Günzel D, Dobrindt U, Epple HJ, et al. Escherichia coli alpha-haemolysin induces focal leaks in colonic epithelium: a novel mechanism of bacterial translocation. Cell Microbiol 2007;9:2530-2540 (Pubitemid 47365655)
17. Hermiston ML, Gordon JI. Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-cadherin. Science 1995;270:1203-1207.
18. Bitton A, Dobkin PL, Edwardes MD, Sewitch MJ, Meddings JB, Rawal S, et al. Predicting relapse in Crohn's disease: a biopsychosocial model. Gut 2008; 57:1386-1392.
19. Heller F, Florian P, Bojarski C, Richter J, Christ M, Hillenbrand B, et al. Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. Gastroenterology 2005;129:550-564. (Pubitemid 41096643)
20. Apostolaki M, Armaka M, Victoratos P, Kollias G. Cellular mechanisms of TNF function in models of inflammation and autoimmunity. Curr Dir Autoimmun 2010;11:1-26.
21. Hehlgans T, Mannel DN. The TNF-TNF receptor system. Biol Chem 2002;383:1581-1585. (Pubitemid 35282977)
22. Ma TY, Boivin MA, Ye D, Pedram A, Said HM. Mechanism of TNF-alpha modulation of Caco-2 intestinal epithelial tight junction barrier: role of myosin light-chain kinase protein expression. Am J Physiol Gastrointest Liver Physiol 2005;288:G422-430.
23. Guy-Grand D, DiSanto JP, Henchoz P, Malassis-Séris M, Vassalli P. Small bowel enteropathy: role of intraepithelial lymphocytes and of cytokines (IL-12, IFN-gamma, TNF) in the induction of epithelial cell death and renewal. Eur J Immunol 1998;28:730-744. (Pubitemid 28101750)
24. Gitter AH, Bendfeldt K, Schulzke JD, Fromm M. Leaks in the epithelium barrier caused by spontaneous and TNF-alpha-induced single-cell apoptosis. FASEB J 2000;14:1749-1753.
25. Schulzke JD, Bojarski C, Zeissig S, Heller F, Gitter AH, Fromm M. Disrupted barrier function through epithelial cell apoptosis. Ann N Y Acad Sci 2006;1072:288-299. (Pubitemid 44448461)
26. von Boyen GB, Steinkamp M, Geerling I, Reinshagen M, Schäfer KH, Adler G, et al. Pro-inflammatory cytokines induce neurotrophic factor expression in enteric glia: a key to the regulation of epithelial apoptosis in Crohn's disease. Inflamm Bowel Dis 2006;12:346-354.
27. Schmitz H, Fromm M, Bentzel CJ, Scholz P, Detjen K, Mankertz J, et al. Tumor necrosis factor-alpha (TNF alpha) regulates the epithelial barrier in the human intestinal cell line HT-29/B6. J Cell Sci 1999;112(pt 1):137-146. (Pubitemid 29043841)
28. Bruewer M, Samarin S, Nusrat A. Inflammatory bowel disease and the apical junctional complex. Ann N Y Acad Sci 2006;1072:242-252. (Pubitemid 44448457)
29. Clayburgh DR, Shen L, Turner JR. A porous defense: the leaky epithelial barrier in intestinal disease. Lab Invest 2004;84:282-291. (Pubitemid 41656483)
30. Laukoetter MG, Bruewer M, Nusrat A. Regulation of the intestinal epithelial barrier by the apical junctional complex. Curr Opin Gastroenterol 2006;22:85-89. (Pubitemid 44090070)
31. Gibson PR. Increased gut permeability in Crohn's disease: is TNF the link? Gut 2004;53:1724-1725.
32. Hollander D. Crohn's disease, TNF-alpha, and the leaky gut: the chicken or the egg? Am J Gastroenterol 2002; 97:1867-1868.
33. Stallmach A, Giese T, Schmidt C, Ludwig B, Mueller-Molaian I, Meuer SC. Cytokine/chemokine transcript profiles reflect mucosal inflammation in Crohn's disease. Int J Colorect Dis 2004;19:308-315. (Pubitemid 38868295)
34. Raddatz D, Bockemuhl M, Ramadori G. Quantitative measurement of cytokine mRNA in inflammatory bowel disease: relation to clinical and endoscopic activity and outcome. Eur J Gastroenterol Hepatol 2005;17:547-557. (Pubitemid 40592713)
35. Laukoetter MG, Nava P, Nusrat A. Role of the intestinal barrier in inflammatory bowel disease. World J Gastroenterol 2008;14:401-407. (Pubitemid 351320848)
36. Joos S, Brinkhaus B, Maluche C, Maupai N, Kohnen R, Kraehmer N, et al. Acupuncture and moxibustion in the treatment of active Crohn's disease: a randomized controlled study. Digestion 2004;69:131-139. (Pubitemid 38813022)